Larmor Bio(est 2022) is a Massachusetts Institute of Technology spin-off is a Biotechnology company advancing development and commercialization of proprietary bioplatform technologies capable of high resolution molecular phenotyping of various microsized biological samples. The platform consists of proprietary compact instruments, proprietary software, and proprietary consumables. Unlike existing methods, our methodology doesn’t require the use of harsh chemical reagents and extensive sample preparation. We analyze “live” biology obtaining an unprecedented level of detail that enables rapid, onsite, answers to complex biological problems cost-effectively. We expect our proprietary Bioplatform to revolutionize medical diagnostics and digital health monitoring technology, in large, addressable, growing markets with significant unmet needs.
Company Details
- Employees
- 9
- Founded
- -
- Address
- Boston, Massachusetts, Us
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://www.larmorbio.com
- HQ
- Boston, Massachusetts
Larmorbio Questions
Larmorbio's website is http://www.larmorbio.com
Larmorbio's LinkedIn profile is https://www.linkedin.com/company/larmorbio
Larmorbio has
9 employees.
View email and phone details for 9
employees at Larmorbio.
Larmorbio's industry is
Biotechnology Research
Larmorbio's top competitors are
Field Labs,
Nx Prenatal Inc.,
Cheminpharma,
Carbon 2 Climate,
Tec Labs,
Ybmd,
Captivate Bio,
Alphabioregen, Inc.,
Enleofen Bio,
Zero2.5 Biotech Pte Ltd.
Larmorbio's categories are Biotechnology Research
Larmorbio's founding year is 2021
